SOCFINAF S.A. financials
SOCFINAF S.A.
Country: LU Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
222100G1I5GZATXY2511 Financial statements
(EUR, as reported — unscaled; 108 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €591.4M | €563.1M |
| Other income | €5.9M | €11.7M |
| Employee benefits expense | €78.6M | €78.9M |
| Raw materials & consumables used | €195.8M | €198.0M |
| Operating profit (EBIT) | €118.6M | €105.2M |
| Finance costs | €37.0M | €43.0M |
| Profit before tax | €113.8M | €84.9M |
| Profit for the year | €81.8M | €49.3M |
| — attributable to owners | €56.8M | €28.2M |
| — attributable to NCI | €25.0M | €21.1M |
| Total comprehensive income | €70.2M | -€14.2M |
| Per share | ||
| Basic EPS | €3.18 | €1.58 |
| Diluted EPS | €3.18 | €1.58 |
| Cash flow statement | ||
| Net cash from operating activities | €145.2M | €147.0M |
| Net cash from investing activities | -€43.7M | -€48.5M |
| Net cash from financing activities | -€99.2M | -€105.5M |
| Dividends paid | €14.2M | €20.9M |
| Proceeds from borrowings | €3.1M | €3.6M |
| Repayments of borrowings | €71.2M | €66.7M |
| Lease liability payments | €3.7M | €4.6M |
| Balance sheet | ||
| Total assets | €798.5M | €797.0M |
| Non-current assets | €599.6M | €600.1M |
| Property, plant & equipment | €227.4M | €232.8M |
| Right-of-use assets | €31.5M | €29.2M |
| Inventories | €102.1M | €88.7M |
| Trade & other receivables | €32.3M | €27.2M |
| Cash & equivalents | €40.5M | €39.7M |
| Total equity | €525.2M | €463.9M |
| — attributable to owners | €421.8M | €363.9M |
| Non-controlling interests | €103.4M | €100.0M |
| Non-current liabilities | €106.7M | €166.1M |
| Long-term borrowings | €38.4M | €102.8M |
| Lease liabilities (non-current) | €26.2M | €25.0M |
| Lease liabilities (current) | €3.3M | €2.8M |
| Deferred tax liabilities | €27.7M | €24.6M |
| Derived metrics | ||
| Operating margin | 20.1% | 18.7% |
| Net margin | 13.8% | 8.8% |
| Return on equity | 15.6% | 10.6% |
| Cash conversion ratio | 1.78× | 2.98× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€11.0M | -€6.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€2.3M | -€15.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €59.8M | €68.6M |
| Adjustments For Fair Value Gains Losses | -€7.4M | €9.7M |
| Adjustments For Income Tax Expense | €36.7M | €41.5M |
| Adjustments For Increase Decrease In Trade and Other Payables | €412.8K | €9.1M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€547.1K | €188.8K |
| Adjustments For Undistributed Profits of Associates | €4.7M | €6.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €35.4M | €36.3M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €174.0M | €176.9M |
| Changes In Inventories of Finished Goods and Work In Progress | -€4.5M | -€9.2M |
| Comprehensive Income Attributable To Noncontrolling Interests | €19.6M | €6.4M |
| Comprehensive Income Attributable To Owners of Parent | €50.6M | -€20.6M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €198.9M | €190.5M |
| Current Biological Assets | €2.3M | €2.1M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €60.1M | €64.1M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €166.7M | €166.6M |
| Current Provisions | €713.5K | €597.9K |
| Current Tax Assets Current | €6.1M | €9.5M |
| Current Tax Expense Income | €37.7M | €36.6M |
| Current Tax Liabilities Current | €31.0M | €28.7M |
| Deferred Tax Assets | €12.4M | €2.7M |
| Deferred Tax Expense Income | -€1.0M | €5.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €59.8M | €68.6M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €16.2M | €23.1M |
| Dividends Received Classified As Operating Activities | €3.9M | €8.3M |
| Dividends Recognised As Distributions To Owners Per Share | €0.00 | €0.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€3.1M | -€9.2M |
| Equity and Liabilities | €798.5M | €797.0M |
| Finance Income | €31.7M | €22.9M |
| Gains On Disposals of Noncurrent Assets | €2.5M | €153.6K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€105.8K | -€602.1K |
| Income Taxes Paid Refund Classified As Operating Activities | €30.0M | €35.2M |
| Increase Decrease In Cash and Cash Equivalents | -€832.8K | -€16.7M |
| Increase Decrease In Working Capital | €9.7M | €9.0M |
| Increase Decrease Through Transactions With Owners | -€9.0M | -€7.2M |
| Increase Decrease Through Transfers and Other Changes Equity | -€17.7K | €9.1K |
| Intangible Assets Other Than Goodwill | €807.1K | €991.7K |
| Interest Paid Classified As Financing Activities | €11.2M | €14.7M |
| Interest Received Classified As Investing Activities | €392.7K | €419.7K |
| Investments In Associates Accounted For Using Equity Method | €28.7M | €24.5M |
| Issued Capital | €35.7M | €35.7M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €284.3K |
| Losses On Disposals of Noncurrent Assets | €1.9M | €342.4K |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €6.3M |
| Noncurrent Biological Assets | €288.6M | €300.0M |
| Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income | €4.8M | €4.8M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €13.2M | €12.5M |
| Other Adjustments For Noncash Items | -€4.8M | €4.3M |
| Other Comprehensive Income | -€11.6M | -€63.5M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€631.0K | -€1.5M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€11.0M | -€62.3M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€525.3K | -€866.2K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€11.0M | -€62.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€525.3K | -€866.2K |
| Other Current Payables | €20.2M | €24.0M |
| Other Current Receivables | €15.7M | €23.1M |
| Other Expense By Nature | €21.6M | €14.7M |
| Other Noncurrent Assets | €3.7M | €3.1M |
| Other Noncurrent Payables | €1.3M | €1.3M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.4M | €1.6M |
| Reserve of Exchange Differences On Translation | -€127.2M | -€121.6M |
| Retained Earnings Profit Loss For Reporting Period | €56.8M | €28.2M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | -€337.9K |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €4.7M | €6.0M |
| Share Premium | €87.5M | €87.5M |
| Statutory Reserve | €3.6M | €3.6M |
| Trade and Other Current Payables To Trade Suppliers | €51.4M | €46.4M |
| Weighted Average Shares | 17.8M | 17.8M |
Methodology
Every line item above is a fact tagged in SOCFINAF S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.